Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price118.72 USD
Fair value106.82
Ethical score30.0/100
Our investment reviews on this name
2026-08-29Read Markdown118.71+0.0% to today
2026-07-30Read Markup132.15-10.2% to today
2026-07-02Read Accumulation129.37-8.2% to today
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Fomento Economico Mexicano SAB de CV ADR holds its Accumulation at $118.72. The statistical read favours the buyers, held for 516 days.
As held on the ledger · 2026-09-18
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 516 days
Price at the screen
$118.72
Valuation
22.92 trailing · 22.77 forward price to earnings
Values screen
FAIL· score 30.0
Beta
0.17
The Workings
Five Screens, Shown in Full
Does not pass. Excluded industry: Beverages - Brewers
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Excluded industry: Beverages - Brewers
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-18 screen. The gold marker is the market price at the same screen. The price runs 10.0% above the base estimate.
Third-party analyst targets: 15 covering, consensus Buy. The average target sits +16% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-18 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Ethics block this Mexican Coke bottler
Think of the truck that delivers Coke to corner shops in Guadalajara. FEMSA owns that route, yet the business lands straight on our excluded list because it sits in beverages. At 129 dollars against a fair value of 118, the shares already price in perfection while revenue grows just 6 percent and the forward multiple sits at 24 times.
We pass for the ethical breach first. The narrow moat, 3 percent profit margin and 12 percent return on equity do not change the fact that this remains an industry we have ruled out. Analyst chatter about a 131 dollar target does not move the needle once the screen has spoken.
The real risk is simple: any slip in Mexican volumes or peso moves would hit earnings quickly, and the current premium leaves little room for that outcome. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Mexico and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
FMX trades on the NYSE (the company is based in Mexico). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-29Markdown · changed$118.71-10.2%Entry 5
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 10.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $125.
2026-07-30Markup · changed$132.15+2.1%Entry 4
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $125.
2026-07-18Accumulation$129.37+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (15 analysts) rates it buy, with a mean price target of $125.
2026-07-03Accumulation$129.37+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Accumulation$129.37Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.